Nomura Downgrades Pharmacyclics To Neutral


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Analysts at Nomura downgraded

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Pharmacyclics Inc. (NASDAQ: PCYC) from Buy to Neutral. The price target for Pharmacyclics has been raised from $196 to $261.25. Pharmacyclics shares have climbed 93.26% over the past 52 weeks, while the S&P 500 index has gained 11.87% in the same period.Pharmacyclics' shares climbed 10.30% to close at $254.22 yesterday.
Posted In: DowngradesAnalyst RatingsNomura